Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Cash from Investing Activities: 2010-2024

Historic Cash from Investing Activities for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -$291,718.

  • China Pharma Holdings' Cash from Investing Activities fell 540.33% to -$40,598 in Q3 2025 from the same period last year, while for Sep 2025 it was -$404,336, marking a year-over-year decrease of 594.01%. This contributed to the annual value of -$291,718 for FY2024, which is 2432.93% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Cash from Investing Activities is -$291,718, which was down 2,432.93% from -$11,517 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Cash from Investing Activities registered a high of -$11,517 during FY2023, and its lowest value of -$867,307 during FY2020.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$291,718 (2024), whereas its average is -$235,066.
  • In the last 5 years, China Pharma Holdings' Cash from Investing Activities surged by 97.13% in 2023 and then slumped by 2,432.93% in 2024.
  • Yearly analysis of 5 years shows China Pharma Holdings' Cash from Investing Activities stood at -$867,307 in 2020, then skyrocketed by 49.49% to -$438,055 in 2021, then grew by 8.24% to -$401,964 in 2022, then skyrocketed by 97.13% to -$11,517 in 2023, then plummeted by 2,432.93% to -$291,718 in 2024.